PlainIndex

ETF comparison

MCHI vs VXUS

International Emerging vs International Total.

iShares MSCI China ETF · Vanguard Total International Stock Index Fund ETF Shares

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of MCHI and VXUS would leave roughly 0.0% of each dollar exposed to the same underlying securities.

MCHI only 0.0% Shared 0.0% VXUS only 0.0%
In MCHI only
0 positions
Shared
0 positions
In VXUS only
0 positions

Holdings data for MCHI covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for VXUS covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

MCHI

iShares MSCI China ETF

iShares · International Emerging

64 composite / 100
Expense ratio
0.59%
Net assets
$6.75B
TTM yield
2.21%
Top-10 conc.
—
VXUS

Vanguard Total International Stock Index Fund ETF Shares

Vanguard · International Total

91 composite / 100
Expense ratio
0.050%
Net assets
$629.15B
TTM yield
2.76%
Top-10 conc.
—

Sub-score comparison

41
Cost
95
72
Tax efficiency
73
93
Liquidity
100
N/A
Concentration
N/A
—
Tracking quality
—
MCHI sub-score VXUS

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

VXUS is 54 bps cheaper than MCHI. On a $100,000 position that's about $540/yr more in fees for MCHI.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in MCHI

0 total

Every MCHI position is also held by VXUS.

Only in VXUS

0 total

Every VXUS position is also held by MCHI.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.